Use of mangiferin as a non-drug phytotherapy strategy in the treatment of type 2 diabetes mellitus: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i10.32318Keywords:
Type 2, diabetes mellitus; Phytotherapeutic Drugs; Mangifera; Plants, Medicinal.Abstract
Mangifera Indica Linn is the scientific name for the popularly known mango, and this plant contains many beneficial properties for health. Humans are able to use its leaves, extract, trunk bark, because it contains an active substance named mangiferin which has numerous medicinal properties. As it is a natural and low-cost product for consumers, it can be a complementary herbal medicine strategy for several pathologies, including Type 2 Diabetes Mellitus (DM2). Mangiferin has several properties as antioxidant, antidiabetic, anticancer, anti-inflammatory, antitumor, antiviral, anthelmintic, antibacterial, antihypertensive, among other chronic non-communicable diseases. General objective: describe the main findings in the literature about the use of the herbal medicine of mangiferin in the prevention and/or treatment of DM2. Methodology: an integrative review was adopted, through the PICO strategy, including research in Portuguese and English available in several scientific databases on the platforms: Scielo, PubMed, Sciencedirect. Results: data obtained from literature suggest the use of mangiferin as a prophylactic strategy in the auxiliary treatment of DM2, which can enhance the reduction in the consumption of industrialized drugs, as well as in the prevention of diseases. Conclusion: through the integrative review, it was possible to identify that mangiferin demonstrates a great potential in the treatment not only of DM2, as well as in other chronic non-communicable diseases.
References
Ali, B. A., Alfa, A. A., Tijani, K. B., Idris, E. T., Unoyiza, U. S. & Junaidu, Y. (2020). (Nutritional Health Benefits and Bioactive Compounds of Mangifera indica L (Mango) Leaves Methanolic Extracts. Asian Plant Research Journal. Cuba, v.6, n.2, p. 41-51. doi: 10.9734/APRJ/2020/v6i230126
Basha, D. P., Kumar, K. P., Teja, B. B., & Subbarao, M. (2011). Antidiabetic activity on extracts of Mangifera indica in alloxan monohydrate induced diabetic rats. Drug Invention Today, 3(7), 165-168. Retrieved from: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.734.8335&rep=rep1&type=pdf
Bezerra, C. (2021). Possíveis efeitos colaterais dos remédios para a diabetes. Retreived from: https://www.tuasaude.com/efeitos-colaterais-dos-remedios-para-a-diabetes/.
Borges, K.B., Bautista, H.B. & Guilera, S. (2008). Diabetes - Utilização de plantas medicinais como forma opcional de tratamento. Revista Eletrônica de Farmácia, v.5, n.2, p.12-20. https://doi.org/10.5216/ref.v5i2.5149
Brasil, Ministério da Saúde. (2011). Planos de Ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis (DCNT) no Brasil. Brasília.
Brasil, Ministério da Saúde. (2016). Dia Nacional do Diabetes. Brasília.
Brasil, Ministério da Saúde. (2013). Estratégias para o cuidado da pessoa com doença crônica: diabetes mellitus. Brasília.
Caetano, M. M. M., Toledo, R. C. L., Brito, L. F. & Queiroz, J. H. (2015). Efeito da mangiferina e do extrato das folhas de manga ubá (mangífera indica l) na modulação da expressão do receptor pparα e do fator de transcrição nfκb no tecido cerebral de animais induzidos à síndrome metabólica. São Paulo, v.1, n.1, p. 7-8. doi: 10.5151/biochem-jaibqi-0097
Canuto, K. M. (2009). Propriedades Químicas e Farmacológicas de Mangiferina: Um Composto Bioativo de Manga (Mangifera indica L). EMBRAPA–Semi Árido - Petrolina – PE. Retrieved from: https://www.infoteca.cnptia.embrapa.br/bitstream/doc/152169/1/SDC218.pdf.
Carvalho, A. C. da S. (2008). Estudos pré-clínicos do efeito gastroprotetor da mangiferina, uma glicosilxantona isolada de Mangifera indica L., em modelos experimentais de lesão gástrica aguda. 2008. 130 f. Dissertação (Mestrado em Farmacologia) - Faculdade de Medicina, Universidade Federal do Ceará. Retrieved from: http://www.repositorio.ufc.br/handle/riufc/2196.
Deepa, P, Sowndhararajan, K., Kim, S. & Park, S.J. (2018). A role of Ficus species in the management of diabetes mellitus: A review. J Ethnopharmacol. doi: 10.1016/j.jep.2017.12.045.
Flor, L. S. & Campos, M. R. (2017). Prevalência de diabetes mellitus e fatores associados na população adulta brasileira: evidências de um inquérito de base populacional. Rev. Bras. Epidemiológica, v.20, n.1, p. 16-29. https://doi.org/10.1590/1980-5497201700010002.
Freitas, A. M. M., Belido, B. M., Silva, R. A. R & Kury, C.M.D. (2021). Novos Tratamentos para o Diabetes Mellitus Tipo 2. Rev. Científica da FMC, Rio de Janeiro.v.16. n.2. https://doi.org/10.29184/1980-7813.rcfmc.506.vol.16.n2.2021.
Garcia, M. G., Laime, S. G., Léon, A.A., Montalvo, A.R., Garrido, G. & Selles, A. N. (2004). Uso etnomédico de la corteza de Mangifera indica L. en Cuba. Rev. Cubana Plant Med [online]., vol.9, n.1. Retrieved from: https://pesquisa.bvsalud.org/portal/resource/pt/lil-394334.
Garrido, G., González, D., Lemus, Y., Garcia, D., Lodeiro, L., Quintero, G., Delporte, C., Núñez, A.J. & Delgado, R. (2004). In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (Vimango). Pharmacological Research, v.50, p. 143–149. https://doi.org/10.1016/j.phrs.2003.12.003.
Gonçalves, M.R., Harzheim, E., Zils, A.A. & Duncan, B.B. (2013). A qualidade da atenção primária e o manejo do diabetes mellitus. Rev. Bras. Med. Fam. Comunidade. v.8, n.29, p.:235-43. https://doi.org/10.5712/rbmfc8(29)814.
Gondi,M. & Prasada, R.U.J. (2015). Ethanol extract of mango (Mangifera indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats. Journal of Food Science and Technology, v. 52, n. 12, p. 7883-7893. https://doi.org/10.1007/s13197-015-1963-4.
International Diabetes Federation, Diabetes Atlas. (2021). – 10th edition. Retrieved from: www.diabetesatlas.org.
Ishola, I. O., Awodele.O. & Eluogu, O.C. (2016). Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action. Journal of Complementary and Integrative Medicine v.13 n.3 p. 275-287. https://doi.org/10.1515/jcim-2015-0047.
Kumar, M., Saurabh, V., Tomar, M. Hasan, M., Changan, S., Sasi, M., Maheshwari, C., Prajapalti, U., Singh, S., Prajapat, R. K., Dhumal, S., Punia, S., Amarowicz, R. & Mekhemar, M. (2021). Mango (Mangifera indica L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities. Antioxidants v.10, p.299. https://doi.org/10.3390/antiox10020299.
Matkowski, A., Kus P., Goralska, E. & Wozniak D. (2013). Mangiferin a bioactive xanthonoid, not only from mango and not just antioxidant. Rev. Med Chem v.13: p.439-455. https://doi.org/10.2174/138955713804999838.
Mendonça, V. M., Santos,J .C.M., Moreira, F. V., Mann, R. S. & Ribeiro, M. J. B. (2018). Fitoterapia tradicional e práticas integrativas e complementares no sistema de saúde do Brasil – tema em saúde, João Pessoa v. 18, n. 1- ISSN 2447-2131. Retrieved from: https://repositorio.ifs.edu.br/biblioteca/handle/123456789/834.
Ojewole, J. A. O. (2005). Antiinflammatory, analgesic and hypoglycemic effects of Mangifera indica Linn. (Anacardiaceae) stem-bark aqueous extract. Methods and Findings in Experimental and Clinical Pharmacology, Barcelona, v.27, p. 547-554.
OMS, Organização Mundial de Saúde. OMS Revela principais causas de morte e incapacidade em todo o mundo entre 2000 e 2019. (2020). Retrieved from: https://www.bio.fiocruz.br/index.php/br/noticias/2116-oms-revela-principais-causas-de-morte-e-incapacidade-em-todo-o-mundo-entre-2000-e-2019.
Pardo-andreu, G. L., Barrios, M.F., Curti. C., Hernández. I., Merino, N., Lemus, Y., Martinez, I., Riaño, A. & Delgado, R. (2008). Protective effects of Mangifera indica L extract (Vimang), and its major component mangiferin, on ironinduced oxidative damage to rat serum and liver. Pharmacological Research, v.57, p. 79–86. https://doi.org/10.1016/j.phrs.2007.12.004.
Patel, D, K., Kumar, R., Laloo, D. & Hemalatha, S. (2012). Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pacific Journal of Tropical Disease. India p. 239-250. https://doi.org/10.1016/S2222-1808(12)60054-1.
Patnaik, R. (2017). Mango Leaves in Treating Diabetes: A Strategic Study. International Journal Of Innovative Research & Development- IMT Nagpur, India, vol. 3 edição 12. Retrieved from: http://52.172.159.94/index.php/ijird_ojs/article/view/135519/94643.
Pasqualotto, K.R., Alberton, D. & Frigeri, H.R. (2012). Diabetes mellitus and Complications. Journal of Biotechnology and Biodiversity. v. 3, n.4, p. 134-145, nov. Retrieved from: https://pt.scribd.com/document/375995190/Diabetes-Mellitus-e-Complicacoes.
Pinto, D. C. A. (2017). Isolamento e estudo da interação da mangiferina e derivados sintéticos com albumina sérica humana - Dissertação de Mestrado, RJ. Retrieved from: https://tede.ufrrj.br/jspui/bitstream/jspui/4444/2/2017.pdf.
Rodrigues, D. F., Brito, G. E. G. D., Sousa, N. M. D., Rufino, T. M. S., & Carvalho, T. D. D. (2011). Prevalência de fatores de risco e complicações do Diabetes Mellitus Tipo 2 em usuários de uma unidade de saúde da Família. Rev. Bras. de Ciências da Saúde, v. 15, n. 3, p. 277-286. Retrieved from: https://pesquisa.bvsalud.org/portal/resource/pt/lil-613377.
Rodrigues,F.F.L., Santos, M.A., Teixeira, C.R.S., Gonela, J.T., & Zanetti, M.L. (2012). Relação entre conhecimento, atitude, escolaridade e tempo de doença em indivíduos com diabetes mellitus. Acta paulista de enfermagem. v.25, n.2, p.284-90. https://doi.org/10.1590/S0103-21002012000200020.
Saleem, M., Tanvir, Muiz, Akhtar, M. F. Iqbal, M., & Saleem. A. (2019). Antidiabetic Potential of Mangifera indica L. cv. Anwar Ratol Leaves: Medicinal Application of Food Wastes. Medicina, Pakistan. v.55, p.353; doi: 10.3390/medicina55070353.
Saleh, S., Maraghy, N. EL., Reda, E. & Barakat, W. (2014). Modulation of Diabetes and Dyslipidemia in Diabetic Insulin-Resistant Rats by Mangiferin: Role of Adiponectin and TNF-α. Egypt. v. 86, n. 4, pp. 1935-1948, https://doi.org/10.1590/0001-3765201420140212.
Shah K, A., Patel, M. B., Patel, R. J., & Parmar, P. K. (2010). Mangifera Indica (Mango). Pharmacognosy. Rev. January-June, v. 4, p. 7. doi: 10.4103/0973-7847.65325.
Shi, J., LV, H., Tang, C., Li, Y., Huang, J., & Zhang, H. (2021). Mangiferin inhibits cell migration and angiogenesis via PI3K/AKT/mTOR signaling in high glucose- and hypoxia-induced RRCECs. Molecular Medicine REPORTS v.23 p. 473. doi: 10.3892/mmr.2021.12112.
Trebien, H.A. (2012). Medicamentos Benefícios e riscos com ênfase na automedicação.1. ed.Curitiba: UFPR.
Veiga-junior, V. F. (2008). Estudo do consumo de plantas medicinais na Região Centro-Norte do Estado do Rio de Janeiro: aceitação pelos profissionais de saúde e modo de uso pela população. Revista Brasileira de Farmacognosia, v. 18, n. 2, p. 308-313. https://doi.org/10.1590/S0102-695X2008000200027.
Villas boas, G.R., Lemos, J.M.R., Oliveira, M.G., Santos, R.C., Silveira, A.P.S., Bacha, F.B., Ito C.N.A., Cornelius, E. B., Lima F.B.; Rodrigues, A.M.S., Costa, N.B., Bittencourt, F.F., Lima, F.F., Paes, M.M., Gubert, P., & Oesterreich S.A. (2020). Extrato aquoso de Mangifera indica Linn (Anacardiaceae) deixa exerce efeito hipoglicêmico a longo prazo, aumenta a sensibilidade à insulina e os níveis de insulina plasmática em ratos Wistar diabéticos. Mato Grosso do Sul, v.8 n.15. doi: 10.1371/journal.pone.0227105.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Juliana de Souza dos Santos Medeiros; Thaynara Lays Sales Brandão; Maria Eduarda Tavares de Freitas ; Júlia Carolina Lopes Silva ; Sarah Évelin Dias Campos; Jakeline Olindina Francelino
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
